Development of a reverse genetics system for a human rabies virus vaccine strain employed in China

Virus Research

Volumn 149, Issue 1, 2010, Pages 28-35

  Huang, Ying ^a,b   Tang, Qing ^a   Nadin Davis, Susan A ^c   Zhang, Shoufeng ^b   Hooper, Craig D ^d   Ming, Pinggang ^a,e   Du, Jialiang ^a   Tao, Xiaoyan ^a   Hu, Rongliang ^b   Liang, Guodong ^a  

^a NATIONAL INSTITUTE FOR VIRAL DISEASE CONTROL AND PREVENTION   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c Ottawa Laboratory Fallowfield   (Canada)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e Wuhan Institute of Biological Product   (China)

Author keywords

Green fluorescent protein; Rabies virus; Reverse genetics

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; GREEN FLUORESCENT PROTEIN; HAMMERHEAD RIBOZYME; HEPATITIS DELTA VIRUS RIBOZYME; NUCLEOPROTEIN; PHOSPHOPROTEIN; RABIES VACCINE; RIBOZYME; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; BRAIN TISSUE; CELL STRAIN BHK; DNA FLANKING REGION; EXPERIMENTAL MOUSE; EXPRESSION VECTOR; FLUORESCENCE MICROSCOPY; GENE CONSTRUCT; GENETIC TRANSFECTION; INOCULATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RABIES VIRUS; RECOMBINANT PLASMID; RIBOZYME VECTOR; SUCKLING; VIRUS DETECTION; VIRUS RECOMBINANT; VIRUS STRAIN;

ANIMALS; CELL LINE; CHINA; CRICETINAE; GENETIC ENGINEERING; GENETICS, MICROBIAL; GREEN FLUORESCENT PROTEINS; HEPATITIS DELTA VIRUS; HUMANS; MICE; PLASMIDS; RABIES; RABIES VACCINES; RABIES VIRUS; RNA, CATALYTIC; SURVIVAL ANALYSIS;

HEPATITIS DELTA VIRUS; MUS; RABIES VIRUS;

EID: 77649183956     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.12.009     Document Type: Article

References (38)

1. Been M.D., and Wickham G.S. Self-cleaving ribozymes of hepatitis delta virus RNA. Eur. J. Biochem. 247 (1997) 741-753
2. Conzelmann K.K., and Schnell M. Rescue of synthetic genome RNA analogs of rabies virus by plasmid-encoded proteins. J. Virol. 68 (1994) 713-719
3. Coslett G.D., Holloway B.P., and Obijeski J.F. The structural proteins of rabies virus and evidence for their synthesis from separate monocistronic RNA species. J. Gen. Virol. 49 (1980) 161-180
4. Dietzschold B., Wunner W.H., Wiktor T.J., Lopes A.D., Lafon M., Smith C.L., and Koprowski H. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 70-74
5. Du J.L., Zhang Q., Tang Q., Li H., Tao X.Y., Morimoto K., Nadin-Davis S.A., and Liang G.D. Characterization of human rabies virus vaccine strain in China. Virus Res. 135 (2008) 260-266
6. Faber M., Pulmanausahakul R., Nagao K., Prosniak M., Rice A.B., Koprowski H., Schnell M.J., and Dietzschold B. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16328-16332
7. Faber M., Faber M.L., Papaneri A., Bette M., Weihe E., Dietzschold B., and Schnell M.J. A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J. Virol. 79 (2005) 14141-14148
8. FDA, Points to Consider on Plasmid DNA Vaccines Preventive Infectious Disease Indications, Published December 22, 1996, Docket No. 96N-0400.
9. Haseloff J., and Gerlach W.L. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334 (1988) 585-591
10. Holloway B.P., and Obijeski J.F. Rabies virus-induced RNA synthesis in BHK21 cells. J. Gen. Virol. 49 (1980) 181-195
11. Inoue K., Shoji Y., Kurane I., Iijima T., Sakai T., and Morimoto K. An improved method for recovering rabies virus from cloned cDNA. J. Virol. Methods 107 (2003) 229-236
12. Ito N., Takayama-Ito M., Yamada K., Hosokawa J., Sugiyama M., and Minamoto N. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol. Immunol. 47 (2003) 613-617
13. Ito N., Takayama M., Ymada K., Sugiyama M., and Minamoto N. Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulences for adult mice. J. Virol. 75 (2001) 9121-9128
14. Khawplod P., Inoue K., Shoji Y., Wilde H., Ubol S., Nishizono A., Kurane I., and Morimoto K. A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein. J. Virol. Methods 125 (2005) 35-40
15. Le Mercier P., Jacob Y., Tanner K., and Tordo N. A novel expression cassette of lyssavirus shows that the distantly related Mokola virus can rescue a defective rabies virus genome. J. Virol. 76 (2002) 2024-2027
16. Liu Z.Y., Yuan H.J., Zhu W.Y., Jiang T., Chen S.P., Yu M., Qin C.F., and Qin E.D. Construction and identification of rabies virus vector. Chin. J. Zoonoses 24 (2008) 1047-1051
17. McGettigan J.P., Pomerantz R.J., and Schnell M.J. Second-generation rabies virus-based vaccine vector expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic. J. Virol. 77 (2003) 237-244
18. McGettigan J.P., Naper K., Orenstein J., Koser M., McKenna P.M., and Schnell M.J. Functional human immunodeficiency virus type 1(HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env expressed from a single rhabdovirus-based vaccine vector genome. J. Virol. 77 (2003) 10889-110889
19. McGettigan J.P., Sarma S., Orenstein J.M., Pomerantz R.J., and Schnell M.J. Expression and immunogenicity of human immunodeficiency virus type 1 gag expressed by a replication-competent rhabdovirus-based vaccine vector. J. Virol. 75 (2001) 8724-8732
20. Mebatsion T. Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein. J. Virol. 75 (2001) 11496-11502
21. Mebatsion T., Schnell M.J., Cox J.H., Finke S., and Conzelmann K.K. Highly stable expression of a foreign gene from rabies virus vectors. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7310-7314
22. Meng S.L., Yan J.X., Xu G.L., Nadin-Davis S.A., Ming P.G., Liu S.Y., Wu J., Ming H.T., Zhu F.C., Zhou D.J., Xiao Q.Y., Dong G.M., and Yang X.M. A molecular epidemiological study targeting the glycoprotein gene of rabies virus isolates from China. Virus Res. 124 (2007) 125-138
23. Ming P.G., Du J.L., Tang Q., Yan J.X., Nadin-Davis S.A., Li H., Tao X.Y., Huang Y., Hu R.L., and Liang G.D. Molecular characterization of the complete genome of a street rabies virus isolated in China. Virus Res. 143 (2009) 6-14
24. Ohkawa J., Koguma T., Kohda T., and Taira K. Ribozymes: from mechanistic studies to applications in vivo. J. Biochem. 118 (1995) 251-258
25. Plesa G., McKenna P.M., Schnell M.J., and Eisenlohr L.C. Immunogenicity of cytopathic and noncytopathic viral vector. J. Virol. 80 (2006) 6259-6266
26. Tang Q., Orciari L.A., Rupprecht C.E., Zhao X.Q., Li Z.G., and Yang W.S. Sequencing and position analysis of the glycoprotein gene of four Chinese rabies viruses. Virol. Sin. 15 (2000) 22-33
27. Schnell M.J., Buonocore L., Whitt M.A., and Rose J.K. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J. Virol. 70 (1996) 2318-2323
28. Schnell M.J., Mebatsion T., and Conzelmann K.K. Infectious rabies viruses from cloned cDNA. EMBO J. 13 (1994) 4195-4203
29. Schnell M.J., Tan G.S., and Dietzschold B. The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines. J. Neurovirol. 11 (2005) 76-81
30. Seif I., Coulon P., Rollin P.E., and Flamand A. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 53 (1985) 926-934
31. Sigurdsson S.T., and Eckstein F. Structure-function relationships of hammerhead ribozymes: from understanding to applications. Trends Biotechnol. 13 (1995) 286-289
32. Tanner N.K. Ribozymes: the characteristics and properties of catalytic RNAs. Microbiol. Rev. 23 (1999) 257-275
33. Takayama-Ito M., Ito N., Yamada K., Sugiyama M., and Minamoto N. Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice. Virus Res. 115 (2006) 169-175
34. Wu X., and Rupprecht C.E. Glycoprotein gene relocation in rabies virus. Virus Res. 131 (2008) 95-99
35. Wunner W.H. Rabies virus. In: Jackson A.C., and Wunner W.H. (Eds). Rabies. 2nd ed. (2007), Academic Press, London, 23-68
36. Xu G.L., Ku L., Wu J., De Mattos C.A., Zheng X.X., Xue J.G., Hu Q.L., Liu J.Y., Zhu J.H., De Mattos C.C., and Smith J.S. Sequence analysis of N gene among 19 rabies virus street isolates from China. Chin. J. Virol. 18 (2002) 48-51
37. Yan Z.L., Han X.J., Ji Y.J., Song Z.Z., and Yu Y.X. Studies on the passage and adaptation of a rabies street virus in mice brain and human diploid cell strain. Chin. J. Microbiol. Immunol. 3 (1983) 305-307
38. Yu Y.X. Development and status quo of domestic and abroad rabies vaccines. Shanghai J. Prev. Med. 18 (2006) 216-218